Live Research Database
Eczema
Hub: Portland, OR
Connecting patients in Portland with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Oregon
Available Eczema Opportunities
10 RecruitingNCT07003425(Verify)
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RECRUITING
Eczema
NCT06311682(Verify)
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
RECRUITING
Eczema
NCT07265479(Verify)
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
RECRUITING
Eczema
NCT07037901(Verify)
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING
Eczema
NCT07230860(Verify)
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06863961(Verify)
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT07217015(Verify)
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06241118(Verify)
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
RECRUITING
Eczema
NCT06389136(Verify)
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RECRUITING
Eczema
NCT06461897(Verify)
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Eczema research in Portland through safe, transparent, and patient-first clinical trials."
Research Hubs in Portland
Explore other local breakthroughs
Eczema Hubs in OR
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT